Lymphoma | PeaceHealth
PeaceHealth St. Joseph Medical Center

Lymphoma

  • MAGNIFY:  Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma

  • E1411:  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma 

  • E1412:  Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma

For more information, contact Cheryl Patz, RN, OCN, CCRC, at 360-788-8238.